Discussion of the "White Paper of the PhRMA Working Group on adaptive dose-ranging designs".
Wang
Sue-Jane
SJ
Center for Drug Evaluation and Research, US Food and Drug Administration, Rockvill 20857-0001, Maryland, USA. suejane.wang@fda.hhs.gov
D015982:Bias; D002986:Clinical Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data; D004305:Dose-Response Relationship, Drug; D004345:Drug Industry; D006801:Humans; D012107:Research Design